Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 11, 2002, Pages 804-807

  Ouedraogo Traore, R ^a   Hoiby E A ^b   Sanou, I ^a   Sangare, L ^a   Kyelem, N ^a   Ye Ouattara, D ^a   Froholm L O ^b   Caugant, Dominique A ^b  

^a University Hospital Yalgado Ouedraogo   (Burkina Faso)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL DNA; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; PENICILLIN G; RIFAMPICIN; SULFADIAZINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL GENETICS; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; BURKINA FASO; CEREBROSPINAL FLUID CULTURE; CHILD; CLINICAL ARTICLE; CLONE; EPIDEMIC; FEMALE; GENE SEQUENCE; HUMAN; INFANT; MALE; NEISSERIA MENINGITIDIS; NORWAY; POLYMERASE CHAIN REACTION; RELIGION; SEQUENCE ANALYSIS; SEROLOGY; SEROTYPE;

EID: 0036965772     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Moore PS. Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin Infect Dis 1992; 14: 515-25.
2. Tikhomirov E, Santamaria M, Esteves K. Meningococcal disease: public health burden and control. World Health Stat Q 1997; 50: 170-7.
3. Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998; 106: 505-25.
4. Zhu P, van der Ende A, Falush D, Brieske N, Morelli G, Linz B, et al. Fitgenotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci U S A 2001; 98: 5234-9.
5. World Health Organization. Epidemics of meningococcal disease, African meningitis belt, 2001. Wkly Epidemiol Rec 2001; 76: 282-8.
6. Gillespie SH. Examination of specimens from the central nervous system. Medical microbiology illustrated. Oxford, UK: Butterworth-Heinemann, 1994: 171-8.
7. Ajello GW, Feeley JC, Hayes PS, Reingold AL, Bolan G, Broome CV, et al. Trans-Isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae. J Clin Microbiol 1984; 20: 55-8.
8. Riou JY, Guibourdenche M. Laboratory methods: Neisseria and Branhamella. Paris: Editions Pasteur, 1993.
9. Wedege E, Høiby EA, Rosenqvist E, Frøholm LO. Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot blotting and ELISA. J Med Microbiol 1990; 31: 195-201.
10. Maiden MCJ, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998; 95: 3140-5.
11. Caugant DA, Bol P, Høiby EA, Zanen HC, Frøholm LO. Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958 through 1986. J Infect Dis 1990; 162: 867-74.
12. Caugant DA, Høiby EA, Frøholm LO, Brandtzæg P. Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian meningococcal serogroup B protection trial. Scand J Infect Dis 1996; 28: 149-53.
13. Taha M-K. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 2000; 38: 855-7.
14. Rådstrøm P, Bäckman A, Qian N, Kragsbjerg P, Pahlson C, Olcen P. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J Clin Microbiol 1994; 32: 2738-44.
15. Jelfs J, Munro R, Wedege E, Caugant DA. Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread. Clin Diagn Lab Immunol 2000; 7: 390-5.
16. Guibourdenche M, Chippaux JP, Ouedraogo-Traore R, Wouafo M, Fagot P, Coulon F, et al. Abstracts of the 10th International Pathogenic Neisseria Conference, Baltimore, MD, 1996.
17. Guibourdenche M, Tioro Gnoumou S, Chippaux JP, Auvigne Catimel B, Ducos M, Riou JY. Abstracts of the 4th Meeting of the European Monitoring Group on Meningococci, Paris, France, 1997.
18. Gagneux SP, Hodgson A, Smith TA, Wirth T, Ehrhard I, Morelli G, et al. Prospective study of a serogroup X Neisseria meningitidis outbreak in Northern Ghana. J Infect Dis 2002; 185: 618-26.
19. Taha M-K, Parent du Chatelet I, Schlumberger M, Sanou I, Djibo S, de Chabalier F, et al. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 2002; 40: 1083-4.
20. World Health Organization. Meningococcal disease in Burkina, Faso - Update 3. 4 April 2002.
21. Public Health Laboratory Services. Meningococcal disease (including W135) in Burkina Faso. Commun Dis Rep CDR Wkly 2002; 4 April.
22. Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, Ajello GW, et al. The 2000 outbreak of W135 meningococcal disease: not emergence of a new W135 strain, but clonal expansion within the ET-37 complex. J Infect Dis 2002; 185: 1596-605.
23. Griffiss JM, Brandt BL, Broud DD. Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines. Infect Immun 1982; 37: 205-8,
24. Pecoul B, Varaine F, Keita M, Soga G, Djibo A, Soula G, et al. Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet 1991; 338: 862-6.